c-Met as a Target for Personalized Therapy

MET and its ligand HGF are involved in many biological processes, both physiological and pathological, making this signaling pathway an attractive therapeutic target in oncology. Downstream signaling effects are transmitted via mitogen-activated protein kinase (MAPK), PI3K (phosphoinositide 3-kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Garajová, Ingrid, Giovannetti, Elisa, Biasco, Guido, Peters, Godefridus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659440/
https://www.ncbi.nlm.nih.gov/pubmed/26628860
http://dx.doi.org/10.4137/TOG.S30534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659440/
https://www.ncbi.nlm.nih.gov/pubmed/26628860
http://dx.doi.org/10.4137/TOG.S30534

Ejemplares similares